Coming up: Cardiovascular benefits of GLP1s – New evidence

4 minute read


Treating obesity is now recommended as part of best practice care for overweight or obese patients who have had an adverse cardiovascular event.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×